RecruitingNCT06538558
Use of Tezampanel for Addiction
This study is recruiting in the United States. It is testing use of Tezampanel for Addiction.
In IndianapolisAddictionDrugA study involving a medication or substance.From 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT07565428
Roluperidone for schizophrenia
This study is recruiting in the United States. It is testing roluperidone for schizophrenia.
Multiple locations, including Culver CitySchizophreniaDrugFrom 18 Years to 55 Years
RecruitingNCT07363577
LB-102 for schizophrenia
This study is recruiting in the United States. It is testing LB-102 for schizophrenia.
Multiple locations, including BentonvilleSchizophreniaDrugFrom 18 Years to 65 Years
RecruitingNCT06088121
ATNC-MDD V1(TMS With Cognitive Training) for Mental health
This study is recruiting in South Korea. It is testing ATNC-MDD V1(TMS With Cognitive Training) for Mental health.
Multiple locations, including IncheonMental healthBehavioralFrom 60 Years to 85 Years
RecruitingNCT07221578
VQW-765 for anxiety
This study is recruiting in the United States. It is testing VQW-765 for anxiety.
Multiple locations, including PhoenixAnxietyDrugFrom 18 Years to 65 Years
RecruitingNCT05303064
Weight Gain for schizophrenia
This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing weight Gain for schizophrenia.
Multiple locations, including DothanBipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
RecruitingISRCTN18262237
Study to investigate the safety of ENX-101 and how well it works in healthy volunteers.
This study is looking at whether Administration of up to 50 mg of ENX-101 or a matching placebo can help people with Epilepsy, spasticity and anxiety or Other. Participants receive a study treatment and complete follow-up visits and assessments.
In NetherlandsAnxietyOtherFrom 18 Years to 55 Years
RecruitingNCT07247968
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
This study is looking at whether a digital support tool can help people with Esketamine, Ect, Depression, or Adolescent. Participants take part in a digital support tool and complete follow-up assessments.
In ChongqingDepressionDrugFrom 13 Years to 17 Years
RecruitingNCT07639359
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including JacksonvilleDepressionDrugFrom 18 Years to 99 Years
RecruitingNCT07492537
SUBDIMA: Subclinical Depression in Acute Myocardial Infarction (SUBDIMA25)
This observational study is following people with Acute Myocardial Infarction or Subclinical Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In RomaDepressionOtherOver 18 Years
RecruitingISRCTN46365995
Subjective well-being, craving for Cannabis and compliance or medication switch in a double blind study with Olanzapine and Risperidone
This study is recruiting in the Netherlands. It focuses on Schizophrenia.
In NetherlandsSchizophreniaOtherOver 18 Years
RecruitingNCT07104123
Substance Use in Pregnant People - Optimizing Retention in Treatment
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BaltimoreAddictionBehavioralOver 18 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.